J Respir Med Lung Dis | Volume 8, Issue 1 | Case Series | Open Access

Inhaled Ibuprofen Case Reports in Chronic Respiratory Pathologies

Carvallo H^1*, Matozza F², Cortiglia A³, Schinca A⁴, Bugarin N³ and Hirsch R⁵

¹Department of Internal Medicine, Universidad Abierta Internamericana, Argentina ²Neuro-Radiologist, Paris, France ³Pharmacologist, Htal. Muñiz, Buenos Aires, Argentina ⁴Department Infectious Diseases, Htal. Muñiz, Buenos Aires, Argentina ⁵Pharmacologist, Htal. Muñiz, Buenos Aires, Argentina

^*Correspondance to: Hector Eduardo Carvallo 

Fulltext PDF

Abstract

A large number of respiratory pathologies have a single factor in common: Inflammation [1]. The limitation they provoke in patients’ quality of life is indisputable, as well as the enormous economic cost that they cause in productive and health systems. Inhaled hypertonic Na-ibuprofenate solution (NIH), has very important characteristics to deal with a high percentage of these disabling pathologies [2].

Keywords:

Inhaled Ibuprofen; Inflammation; Respiratory Pathologies

Citation:

Carvallo H, Matozza F, Cortiglia A, Schinca A, Bugarin N, Hirsch R. Inhaled Ibuprofen Case Reports in Chronic Respiratory Pathologies. J Respir Med Lung Dis. 2023; 8(1): 1062..